Viewing nowMasapo Sustained Release Tablet 300 mg (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

MFDS item code 201903474 · Approved 2019.05.28 · Insurance code 653006390
Improvement of ischemic symptoms such as chronic arterial occlusive disease (ulcers, pain, etc.)
This medication is used to improve ischemic symptoms such as ulcers, pain, and coldness caused by chronic arterial occlusive disease. It may help patients with Buerger's disease, occlusive arteriosclerosis, and diabetic peripheral vascular disease. By promoting blood circulation, it alleviates discomfort and contributes to an improved quality of life. Symptoms can be alleviated through this treatment, reducing inconvenience in daily life.
Sarpogrelate Hydrochloride sustained release tablet 300 mg is administered orally once a day after meals. It should be taken whole without chewing or crushing.
This medication should not be used in patients with bleeding, as it may increase the risk of severe bleeding. It is safer for women who are pregnant or may become pregnant to avoid this medication, as it may affect the fetus. Women who are menstruating or have a tendency to bleed should use this medication with caution, as it may worsen bleeding. Patients taking anticoagulants or antiplatelet agents need to be cautious, as the combination may increase the risk of bleeding. Patients with severely impaired kidney function or the elderly should use this medication with care, as it may affect its excretion. While taking this medication, various side effects such as rashes, dyspepsia, diarrhea, headaches, and cough may occur, so if symptoms are severe, consult a doctor. Regular blood tests are recommended to check for any adverse reactions or bleeding. This medication may increase the risk of bleeding when taken with anticoagulants or antiplatelet agents, so it is essential to consult healthcare professionals before use. It is recommended that pregnant or breastfeeding women do not take this medication, and if it must be taken, breastfeeding should be avoided. Safety for children has not been confirmed, so it is advisable not to use this medication in children. This medication should be kept out of reach of children and not be transferred to other containers to maintain its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air and moisture. It is important to maintain a storage temperature between 1°C and 30°C. Proper storage will help ensure the medication's effectiveness.
White rectangular film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.